# Manzo Pharmaceuticals, Inc — Form D

Manzo Pharmaceuticals, Inc of Toronto, A6, a company, filed a Form D exempt-offering notice with the SEC on 2015-12-10. Industry: Pharmaceuticals.

## Offering

- Filed: 2015-12-10
- Form: D
- Accession: 0001637132-15-000003
- Industry: Pharmaceuticals
- Exemptions: 06c
- Minimum investment: $1K
- Security types: equity, debt
- Revenue range: $1 - $1,000,000
- SEC file number: 021-252734

## Issuer

- Name: Manzo Pharmaceuticals, Inc
- CIK: 0001637132
- Entity type: Corporation
- Jurisdiction: NEVADA
- Address: 222-415 Oakdale Road, Toronto, A6, M3N 1W7
- Phone: 647-393-8417

## Officers, directors & promoters (1)

| Name | Role | Location |
| --- | --- | --- |
| Arthur Douglas Smitherman | Director | Toronto, Z4 |

## More

- [CIK 1637132 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1637132&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001637132-15-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.